Salud financiera de hoja de balance de Baolingbao BiologyLtd
Salud financiera controles de criterios 6/6
Baolingbao BiologyLtd has a total shareholder equity of CN¥2.0B and total debt of CN¥363.5M, which brings its debt-to-equity ratio to 17.9%. Its total assets and total liabilities are CN¥2.7B and CN¥642.1M respectively. Baolingbao BiologyLtd's EBIT is CN¥109.4M making its interest coverage ratio 13.6. It has cash and short-term investments of CN¥276.7M.
Información clave
17.9%
Ratio deuda-patrimonio
CN¥363.52m
Deuda
| Ratio de cobertura de intereses | 13.6x |
| Efectivo | CN¥276.72m |
| Patrimonio | CN¥2.03b |
| Total pasivo | CN¥642.07m |
| Activos totales | CN¥2.68b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up
Oct 08
We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)
Sep 30Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price
Jul 03Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled
Jun 07Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders
May 06Análisis de la situación financiera
Pasivos a corto plazo: 002286's short term assets (CN¥855.8M) exceed its short term liabilities (CN¥585.5M).
Pasivo a largo plazo: 002286's short term assets (CN¥855.8M) exceed its long term liabilities (CN¥56.5M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 002286's net debt to equity ratio (4.3%) is considered satisfactory.
Reducción de la deuda: 002286's debt to equity ratio has reduced from 39.5% to 17.9% over the past 5 years.
Cobertura de la deuda: 002286's debt is well covered by operating cash flow (48.2%).
Cobertura de intereses: 002286's interest payments on its debt are well covered by EBIT (13.6x coverage).